Table 3.
Outcomes, demographic characteristics and co‐existing conditions for SARS‐CoV‐2 infections among adults with HIV in the Western Cape, stratified by wave (percentages and counts).
| Characteristic/outcome |
Wave 1 n = 5783 |
Wave 2 n = 5001 |
Wave 3 n = 5478 |
Wave 4 n = 3430 |
Inter‐wave n = 2361 |
|---|---|---|---|---|---|
| Death | 5.6 (323) | 5.6 (281) | 5.9 (325) | 4.9 (167) | 5.8 (137) |
| Sex | |||||
| Female | 75.2 (4351) | 70.3 (3515) | 67.2 (3681) | 68.9 (2364) | 69.8 (1650) |
| Male | 24.8 (1432) | 29.7 (1486) | 32.8 (1797) | 31.1 (1066) | 30.2 (715) |
| Age (years) | |||||
| 15–24 | 4.8 (279) | 4.1 (204) | 5.1 (277) | 4.7 (161) | 7.8 (185) |
| 25–29 | 11.3 (655) | 10.9 (544) | 10.3 (566) | 12.7 (435) | 13.4 (317) |
| 30–34 | 17.5 (1012) | 16.6 (830) | 15.9 (872) | 20.3 (695) | 18.3 (432) |
| 35–39 | 19.1 (1106) | 17.8 (891) | 18.5 (1016) | 19.5 (669) | 18.9 (448) |
| 40–49 | 28.7 (1657) | 29.7 (1486) | 30.2 (1653) | 26.1 (894) | 26.1 (618) |
| 50–59 | 13.7 (792) | 14.8 (742) | 15.0 (822) | 12.2 (419) | 11.9 (282) |
| 60–69 | 3.9 (225) | 4.7 (233) | 4.0 (217) | 3.7 (127) | 2.6 (62) |
| ≥70 | 1.0 (57) | 1.4 (71) | 1.0 (55) | 0.9 (30) | 0.9 (21) |
| Hypertension | 21.2 (1226) | 21.2 (1062) | 20.0 (1096) | 16.3 (559) | 17.6 (417) |
| Diabetes | 11.8 (684) | 10.1 (506) | 7.6 (418) | 6.2 (212) | 7.6 (179) |
| Chronic obstructive pulmonary disease | 5.9 (343) | 7.7 (384) | 8.1 (442) | 10.6 (365) | 7.6 (180) |
| Chronic kidney disease | 4.0 (233) | 3.7 (183) | 3.4 (187) | 2.8 (95) | 3.6 (86) |
| Tuberculosis a (years since) | |||||
| Absent | 72.2 (4177) | 71.7 (3586) | 67.5 (3695) | 60.8 (2087) | 64.4 (1523) |
| ≥ 1 | 21.5 (1242) | 21.3 (1064) | 23.8 (1303) | 23.3 (800) | 21.2 (502) |
| < 1 | 3.0 (174) | 2.7 (136) | 3.4 (187) | 5.7 (194) | 4.9 (115) |
| Ongoing | 3.3 (190) | 4.3 (215) | 5.3 (293) | 10.2 (349) | 9.5 (225) |
| Pregnancy (in women aged 15–49 years) | 7.1 (263) | 7.5 (216) | 7.0 (215) | 8.1 (165) | 11.7 (169) |
| Number of previous SARS‐CoV‐2 diagnoses | |||||
| 0 | 100.0 (5783) | 98.4 (4920) | 96.9 (5308) | 87.8 (3011) | 97.0 (2294) |
| 1 | 0.0 (0) | 1.6 (81) | 3.0 (166) | 11.8 (406) | 2.9 (69) |
| 2 | 0.0 (0) | 0.0 (0) | 0.1 (4) | 0.4 (13) | 0.1 (2) |
| Number of conditions b | |||||
| 0 | 50.9% (2941) | 50.2% (2509) | 47.9% (2626) | 45.1% (1546) | 47.5% (1124) |
| 1 | 33.1% (1917) | 33.9% (1693) | 37.0% (2028) | 39.1% (1340) | 37.8% (894) |
| 2 | 11.3% (655) | 11.7% (586) | 11.2% (614) | 12.3% (423) | 10.8% (255) |
| ≥3 | 4.7% (270) | 4.3% (213) | 3.8% (210) | 3.5% (121) | 3.9% (92) |
a
Time since the most recent evidence of a start of an episode; with episodes beginning after 2 months before the SARS‐CoV‐2 diagnosis considered as ongoing.
b
Hypertension, diabetes, chronic obstructive pulmonary disease, chronic kidney disease and tuberculosis (at any time).